Biologic outcomes in patients with severe asthma and clinically relevant allergy in the CHRONICLE study

Background: Several mAb biologic therapies are approved for the treatment of severe asthma. There are limited data examining biologic outcomes in patients with allergy that has been clinically confirmed to exacerbate their asthma symptoms. Objective: Our aim was to assess rates of asthma exacerbatio...

Бүрэн тодорхойлолт

Номзүйн дэлгэрэнгүй

Үндсэн зохиолчид:	Bradley E. Chipps, MD, Warner W. Carr, MD, Reynold A. Panettieri, Jr., MD, Weily Soong, MD, Jennifer Trevor, MD, Andrew W. Lindsley, MD, PhD, Christopher S. Ambrose, MD, MBA
Формат:	Artigo
Хэл сонгох:	Inglês
Хэвлэсэн:	Elsevier 2026-01-01
Цуврал:	Journal of Allergy and Clinical Immunology: Global
Нөхцлүүд:	Biologic perennial allergy efficacy exacerbations severe asthma allergists
Онлайн хандалт:	http://www.sciencedirect.com/science/article/pii/S2772829325001912
Шошгууд:	Шошго нэмэх Шошго байхгүй, Энэхүү баримтыг шошголох эхний хүн болох!